Revelation Biosciences, Inc. (REVBW) Ownership

$0.01

south_east
-$0 (11.11%)
Day's range
$0.01
Day's range
$0.01

Revelation Biosciences, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
LINDEN ADVISORS LP 02/14/2025 338,110 $2,513   0.00% 12.62%
YAKIRA CAPITAL MANAGEMENT, INC. 02/13/2025 246,884 $1,728   0.00% 9.21%
PINE VALLEY INVESTMENTS LTD LIABILITY CO 02/04/2025 99,290 $695   -30.15% 3.70%
WALLEYE TRADING LLC 02/13/2025 93,435 $654   -11.01% 3.49%
WOLVERINE ASSET MANAGEMENT LLC 02/03/2025 54,752 $383   146.61% 2.04%
JANE STREET GROUP, LLC 02/14/2025 50,000 $350   0.00% 1.87%
TWO SIGMA SECURITIES, LLC 02/14/2025 10,354 $72   -34.53% 0.39%
WALLEYE CAPITAL LLC 02/13/2025 10,074 $71   -94.61% 0.38%
UBS GROUP AG 02/14/2025 2,512 $18   -5.85% 0.09%
POM INVESTMENT STRATEGIES, LLC 01/29/2025 1,005 $7   0.00% 0.04%

Revelation Biosciences, Inc. institutional Ownership - FAQ's

During the previous two years, 15 institutional investors and hedge funds held shares of Revelation Biosciences, Inc.. The most heavily invested institutionals were:

LINDEN ADVISORS LP: 338,110

Yakira Capital Management, Inc.: 246,884

Pine Valley Investments Ltd Liability Co: 99,290

Walleye Trading LLC: 93,435

WOLVERINE ASSET MANAGEMENT LLC: 54,752

JANE STREET GROUP, LLC: 50,000

35.25% of Revelation Biosciences, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 1.49 M shares in the last 24 months. This purchase volume represents approximately $14,872 in transactions.